Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine effects on ERP in early schizophrenia
NCT02233556Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of memantine in schizophrenia, sponsored by National Taiwan University Hospital. Primary endpoint: Mismatch Negativity at 4 hours. Status: unknown.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02233556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233556.